% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • dawginlife dawginlife May 15, 2012 12:01 PM Flag

    half of this company is owned by retail

    management better care how we feel.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Exactly. I have a call scheduled with the Trout Group, PLXs investor relations, to discuss this on thursday at 4pm EST. Please let me know if you have questions that you want answered. Jarrett

    • I'm not convinced this type of media outlet is as useful as say wsj, ny times, msnbc, Bloomberg, cnn, etc...

      some outlet just get more and better eyeballs. other outlet can be grouped with spam and will probably not be seen by those who would actually be interested.

      with regards to elelyso, in the short term, i just feel it's more important to focus on gaining market share and preparing a strategy for eliglustat in case it gets approved. now is not the time for pr but execution.

    • The sad fact is that when it comes to incubator biotechs, the vast majority of the management are the same scientists who plan and do the research.

      Unfortunately for shareholders these guys are brilliant at the science of what they do but completely ill-prepared and unqualified on the business side.

      Consequently they fall easy prey to the money managers at banks & hedge funds and it's the shareholders who end up paying the price for their business incompetence.

      These guys took chemistry, physics, biology & math when they went to school. You can be certain that they didn't load up on the accounting & finance courses.

      • 5 Replies to itzscott1
      • the company is at the mercy of wall street. unfortunately, this company does not have great name recognition so not a lot of retail know or care about it. there just isn't a lot of media interest.

        a big reason for this is the company's poor choice of gaucher as the lead product. most retail and media just don't care about this indication. zero potential of becoming a blockbuster. most investors can't see past this.

        those who are still invested inspite of this gaucher indication are here for the technology and are willing to wait for the pipeline to mature. without us, this company would have no support.

        the best the company can do for us and themselves is to develope the pipeline and technology. if they do this, wall street will eventually recognize the value.

2.18-0.04(-1.80%)May 22 4:02 PMEDT